1-2 of 2
Mark A. Schroeder
Close
Sort by
Journal Articles

Do somatic mutations in de novo MDS predict for response to treatment?

Mark A. Schroeder, Amy E. DeZern
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 317–328.
https://doi.org/10.1182/asheducation-2015.1.317
Published: 2015
Journal Articles

Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?

Mark A. Schroeder, William Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 322–324.
https://doi.org/10.1182/asheducation-2010.1.322
Published: 2010